Roger A. Alvarez

909 total citations
14 papers, 249 citations indexed

About

Roger A. Alvarez is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Infectious Diseases. According to data from OpenAlex, Roger A. Alvarez has authored 14 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Internal Medicine and 2 papers in Infectious Diseases. Recurrent topics in Roger A. Alvarez's work include Pulmonary Hypertension Research and Treatments (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Roger A. Alvarez is often cited by papers focused on Pulmonary Hypertension Research and Treatments (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Roger A. Alvarez collaborates with scholars based in United States, Switzerland and Spain. Roger A. Alvarez's co-authors include Daniel J. Feaster, Victoria B. Mitrani, Elias Provencio Vasquez, Jeffrey J. Swigris, Lisa Lancaster, Parag S. Shah, Ganesh Raghu, Hunter Gillies, Marilyn K. Glassberg and Steven D. Nathan and has published in prestigious journals such as Journal of Biological Chemistry, CHEST Journal and Annals of Oncology.

In The Last Decade

Roger A. Alvarez

12 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger A. Alvarez United States 5 70 46 45 39 37 14 249
Xiaoyong Sai China 7 52 0.7× 51 1.1× 20 0.4× 67 1.7× 46 1.2× 16 291
Susana Rodríguez‐Domínguez Spain 15 109 1.6× 78 1.7× 45 1.0× 31 0.8× 111 3.0× 39 454
Joël Cogneau France 10 16 0.2× 90 2.0× 39 0.9× 19 0.5× 28 0.8× 16 301
Marie-Ève Rougé Bugat France 10 21 0.3× 55 1.2× 65 1.4× 35 0.9× 15 0.4× 33 246
Divyansh Sharma Australia 8 30 0.4× 31 0.7× 91 2.0× 17 0.4× 84 2.3× 12 326
Sherif Eltonsy Canada 12 32 0.5× 22 0.5× 144 3.2× 48 1.2× 51 1.4× 41 368
Grace Hsu United States 9 23 0.3× 30 0.7× 26 0.6× 17 0.4× 20 0.5× 21 264
Bashir Hanif Pakistan 10 27 0.4× 11 0.2× 32 0.7× 12 0.3× 27 0.7× 58 290
Sandra Serrano Martínez Spain 8 29 0.4× 113 2.5× 224 5.0× 90 2.3× 39 1.1× 15 491

Countries citing papers authored by Roger A. Alvarez

Since Specialization
Citations

This map shows the geographic impact of Roger A. Alvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger A. Alvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger A. Alvarez more than expected).

Fields of papers citing papers by Roger A. Alvarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger A. Alvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger A. Alvarez. The network helps show where Roger A. Alvarez may publish in the future.

Co-authorship network of co-authors of Roger A. Alvarez

This figure shows the co-authorship network connecting the top 25 collaborators of Roger A. Alvarez. A scholar is included among the top collaborators of Roger A. Alvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger A. Alvarez. Roger A. Alvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Macarulla, Teresa, Florian Castet, Rocio García‐Carbonero, et al.. (2023). 1686TiP Olaparib and durvalumab (MEDI4736) phase II study in patients with metastatic pancreatic cancer and DNA damage repair genes alterations. Annals of Oncology. 34. S923–S923. 2 indexed citations
2.
Gonsalves, Carin F., C. Michael Gibson, Stefan Stortecky, et al.. (2023). Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study. American Heart Journal. 266. 128–137. 30 indexed citations
3.
Martinez, Laisel, et al.. (2022). Echocardiographic changes after arteriovenous fistula creation in hemodialysis patients. Clinical Nephrology. 98(5). 229–238. 2 indexed citations
4.
Alvarez, Roger A., et al.. (2022). TENSION PNEUMOMEDIASTINUM RESULTING IN OBSTRUCTIVE SHOCK IN COVID-19. CHEST Journal. 162(4). A1327–A1328.
5.
Nathan, Steven D., Kevin R. Flaherty, Marilyn K. Glassberg, et al.. (2020). A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis. CHEST Journal. 158(2). 637–645. 69 indexed citations
6.
Alvarez, Roger A., et al.. (2020). EMERGENT THROMBECTOMY OF HIGH RISK PE. CHEST Journal. 158(4). A2073–A2073.
7.
Alvarez, Roger A., et al.. (2020). MASSIVE PULMONARY EMBOLISM TREATED WITH THROMBOLYSIS IN COVID-19: A CASE SERIES. CHEST Journal. 158(4). A2126–A2127. 1 indexed citations
8.
9.
10.
Alvarez, Roger A., Megan Miller, Scott Hahn, et al.. (2017). Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction. American Journal of Respiratory Cell and Molecular Biology. 57(6). 733–744. 22 indexed citations
11.
Krick, Stefanie, et al.. (2017). Going with the Flow: Saddle Pulmonary Embolism Complicated by Severe Hypoxemia without Shock. Annals of the American Thoracic Society. 14(9). 1479–1484. 1 indexed citations
12.
Hidalgo, María Jesús Cancelo, María de los Llanos Gil, Rocio García‐Carbonero, et al.. (2016). First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer. European Journal of Cancer. 69. S99–S100. 2 indexed citations
13.
Koes, David Ryan, Anh T. Nguyen, Stephanie M. Mutchler, et al.. (2015). Structure Guided Chemical Modifications of Propylthiouracil Reveal Novel Small Molecule Inhibitors of Cytochrome b5 Reductase 3 That Increase Nitric Oxide Bioavailability. Journal of Biological Chemistry. 290(27). 16861–16872. 22 indexed citations
14.
Alvarez, Roger A., et al.. (2006). Increasing Minority Research Participation Through Community Organization Outreach. Western Journal of Nursing Research. 28(5). 541–560. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyong Sai Breakdown of academic impact, for papers by Susana Rodríguez‐Domínguez Breakdown of academic impact, for papers by Joël Cogneau Breakdown of academic impact, for papers by Marie-Ève Rougé Bugat Breakdown of academic impact, for papers by Divyansh Sharma Breakdown of academic impact, for papers by Sherif Eltonsy Breakdown of academic impact, for papers by Grace Hsu Breakdown of academic impact, for papers by Bashir Hanif Breakdown of academic impact, for papers by Sandra Serrano Martínez
Rankless by CCL
2026